SSY Group Granted Approval to Become Marketing Authorization Holder for Cefotaxime Sodium for Injection

Stock News06-08

SSY GROUP (02005) has announced that the group has received approval from China's National Medical Products Administration to change and become the marketing authorization holder for Cefotaxime Sodium for Injection (1g and 0.5g).

Cefotaxime Sodium for Injection is primarily used to treat lower respiratory tract infections, urinary tract infections, intra-abdominal infections, pelvic infections, septicemia, skin and soft tissue infections, and bone and joint infections caused by susceptible bacteria. It is also indicated for meningitis caused by Streptococcus pneumoniae or Haemophilus influenzae, as well as for uncomplicated gonorrhea.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1105170951?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-08 12:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105170951","market":"nz","top_or_hot":-1,"title":"SSY Group Granted Approval to Become Marketing Authorization Holder for Cefotaxime Sodium for Injection","media":"Stock News","content":"<p><b>SSY GROUP</b> (<b>02005</b>) has announced that the group has received approval from China's National Medical Products Administration to change and become the marketing authorization holder for Cefotaxime Sodium for Injection (1g and 0.5g).<br><br>Cefotaxime Sodium for Injection is primarily used to treat lower respiratory tract infections, urinary tract infections, intra-abdominal infections, pelvic infections, septicemia, skin and soft tissue infections, and bone and joint infections caused by susceptible bacteria. It is also indicated for meningitis caused by Streptococcus pneumoniae or Haemophilus influenzae, as well as for uncomplicated gonorrhea.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SSY Group Granted Approval to Become Marketing Authorization Holder for Cefotaxime Sodium for Injection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSSY Group Granted Approval to Become Marketing Authorization Holder for Cefotaxime Sodium for Injection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-08 12:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>SSY GROUP</b> (<b>02005</b>) has announced that the group has received approval from China's National Medical Products Administration to change and become the marketing authorization holder for Cefotaxime Sodium for Injection (1g and 0.5g).<br><br>Cefotaxime Sodium for Injection is primarily used to treat lower respiratory tract infections, urinary tract infections, intra-abdominal infections, pelvic infections, septicemia, skin and soft tissue infections, and bone and joint infections caused by susceptible bacteria. It is also indicated for meningitis caused by Streptococcus pneumoniae or Haemophilus influenzae, as well as for uncomplicated gonorrhea.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2460026573.USD","symbol_name":"abrdn SICAV I -  CHINA NEXT GENERATION \"A\" (USD) ACC","start_time":0,"source_url":"","article_id":"1105170951","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105170951","pubTimestamp":1780891897,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"SSY GROUP (02005) has announced that the group has received approval from China's National Medical Products Administration to change and become the marketing authorization holder for Cefotaxime...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2460026573.USD":"abrdn SICAV I -  CHINA NEXT GENERATION \"A\" (USD) ACC","BK1191":"制药","IPOS":"Renaissance International IPO ETF","02005":"石四药集团"},"translate_title":"SSY集团获批成为注射用头孢噻肟钠上市许可持有人","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02005":1,"IPOS":1},"content_text":"SSY GROUP (02005) has announced that the group has received approval from China's National Medical Products Administration to change and become the marketing authorization holder for Cefotaxime Sodium for Injection (1g and 0.5g).Cefotaxime Sodium for Injection is primarily used to treat lower respiratory tract infections, urinary tract infections, intra-abdominal infections, pelvic infections, septicemia, skin and soft tissue infections, and bone and joint infections caused by susceptible bacteria. It is also indicated for meningitis caused by Streptococcus pneumoniae or Haemophilus influenzae, as well as for uncomplicated gonorrhea.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1105170951","isCrawlerRequest":true}